Ovoca Bio plc
EEURONEXT:OVXAShare Statistics
As of December 31, 2023, Ovoca Bio plc has 81.56M shares outstanding.
| Shares Outstanding | 81.56M |
Valuation Ratios
These figures are as of December 31, 2023.
| PB Ratio | -0.24 |
| P/TBV Ratio | 0.33 |
| P/FCF Ratio | 0.70 |
| P/OCF Ratio | 0.73 |
Financial Position
As of December 31, 2023, Ovoca Bio plc maintains a current ratio of 3.59, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.59 |
| Quick Ratio | 3.45 |
| Interest Coverage | -373.20 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2023. Return on assets (ROA) is negative at -73.05, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -73.05 |
Dividends & Yields
These figures cover the twelve months ended December 31, 2023. Free cash flow yield stands at 142.71, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 107.77, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Ovoca Bio plc shareholders.
| Shareholder Yield | 107.77 |
| FCF Yield | 142.71 |
Stock Splits
Ovoca Bio plc's most recent stock split took place on January 18, 2010 with a 5:1 split ratio.
| Last Split Date | 1/18/2010 |
| Split Ratio | 5:1 |
Scores
As of December 31, 2023, Ovoca Bio plc has an Altman Z-Score of -6.23, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -6.23 |